PATHOVAX
PathoVax is a biotech start-up from Johns Hopkins commercializing RGVax, the world’s first low-cost Human Papillomavirus (HPV) vaccine targeting all clinically relevant types. Current vaccines target some cancer-causing HPVs and only focus on sexual transmitted types, resulting in low uptake due to the incomplete coverage and social stigma. Established animal studies have confirmed RGVax’s protection against all 15 oncogenic types and the added coverage against skin HPVs positions RGVax as a childhood vaccine, allowing unrivalled early market entry in a segment with superior uptake.
PATHOVAX
Industry:
Biotechnology Clinical Trials Health Care
Founded:
2014-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.pathovax.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.98 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content Facebook Domain Insights Wix
Current Employees Featured
Founder
Investors List
National Science Foundation
National Science Foundation investment in Grant - PathoVax
43North
43North investment in Seed Round - PathoVax
MassChallenge
MassChallenge investment in Non Equity Assistance - PathoVax
Official Site Inspections
http://www.pathovax.com Semrush global rank: 5.46 M Semrush visits lastest month: 1.56 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
